These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 33647814
1. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone. Behrens YL, Schienke A, Davenport C, Lentes J, Tauscher M, Steinemann D, Rasche M, Knirsch S, Joachim S, Reinhardt D, Schlegelberger B, Göhring G. Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814 [Abstract] [Full Text] [Related]
2. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Tirado CA, Valdez F, Klesse L, Karandikar NJ, Uddin N, Arbini A, Fustino N, Collins R, Patel S, Smart RL, Garcia R, Doolittle J, Chen W. Cancer Genet Cytogenet; 2010 Jul 01; 200(1):54-9. PubMed ID: 20513535 [Abstract] [Full Text] [Related]
3. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion. Blackburn PR, Huang L, Dalovisio A, Pitel BA, Chen D, Oliveira JL, Wood AJ, Smadbeck JB, Johnson SH, Vasmatzis G, Haferlach C, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, Peterson JF. Cancer Genet; 2020 Feb 01; 241():67-71. PubMed ID: 31902694 [Abstract] [Full Text] [Related]
4. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Ninomiya S, Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T, Moriwaki H. Int J Hematol; 2011 Jun 01; 93(6):806-810. PubMed ID: 21523337 [Abstract] [Full Text] [Related]
5. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia. Liu K, Hu J, Wang X, Li L. J Clin Lab Anal; 2019 Oct 01; 33(8):e22961. PubMed ID: 31218758 [Abstract] [Full Text] [Related]
6. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia. Pan J, Xue Y, Qiu H, Chen S, Zhang J, Wu Y, Shen J, Wang Y. Cancer Genet Cytogenet; 2010 Dec 01; 203(2):333-40. PubMed ID: 21156255 [Abstract] [Full Text] [Related]
7. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations. Bacher U, Haferlach T, Alpermann T, Zenger M, Hochhaus A, Beelen DW, Uppenkamp M, Rummel M, Kern W, Schnittger S, Haferlach C. Br J Haematol; 2011 Mar 01; 152(6):713-20. PubMed ID: 21275954 [Abstract] [Full Text] [Related]
8. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors. Theil KS, Cotta CV. Cancer Genet; 2014 May 01; 207(5):171-6. PubMed ID: 25027637 [Abstract] [Full Text] [Related]
9. Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. Boucher L, Sorel N, Desterke C, Chollet M, Rozalska L, Gallego Hernanz MP, Cayssials E, Raimbault A, Bennaceur-Griscelli A, Turhan AG, Chomel JC. Int J Mol Sci; 2023 Oct 22; 24(20):. PubMed ID: 37895120 [Abstract] [Full Text] [Related]
10. [Clinical and laboratory investigation of pericentric inv(9)(p22q34) with the der(9)t(9;22)(q34;q11) in Ph-positive leukemia]. Fan Y, Ding SS, Pan JL, Xue YQ, Hu ZH. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr 22; 30(2):157-60. PubMed ID: 23568725 [Abstract] [Full Text] [Related]
11. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study. Gondran C, Dumas PY, Bérard E, Bidet A, Delabesse E, Tavitian S, Leguay T, Huguet F, Borel C, Forcade E, Vergez F, Vial JP, Rieu JB, Lechevalier N, Luquet I, Canali A, Klein E, Sarry A, de Grande AC, Pigneux A, Récher C, Largeaud L, Bertoli S. Blood Cancer J; 2024 May 31; 14(1):91. PubMed ID: 38821940 [Abstract] [Full Text] [Related]
12. Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias. Maiti A, Franquiz MJ, Ravandi F, Cortes JE, Jabbour EJ, Sasaki K, Marx K, Daver NG, Kadia TM, Konopleva MY, Masarova L, Borthakur G, DiNardo CD, Naqvi K, Pierce S, Kantarjian HM, Short NJ. Acta Haematol; 2020 May 31; 143(6):567-573. PubMed ID: 32289808 [Abstract] [Full Text] [Related]
15. Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2). Bustamante D, Chan KR, Czuchlewski DR, Saadi AA. Int J Hematol; 2012 Mar 31; 95(3):324-6. PubMed ID: 22370710 [No Abstract] [Full Text] [Related]
16. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis. Asou H, Eguchi M, Suzukawa K, Morishita K, Tanaka K, Date M, Hamamoto K, Kamada N. Br J Haematol; 1996 Apr 31; 93(1):68-74. PubMed ID: 8611478 [Abstract] [Full Text] [Related]
17. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series. Bayrak AG, Daglar Aday A, Yavuz AS, Nalcaci M, Ozbalak MM, Cefle K, Ozturk S, Palanduz S. Leuk Res; 2021 Dec 31; 111():106725. PubMed ID: 34634595 [Abstract] [Full Text] [Related]
19. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia. Loncarevic IF, Römer J, Starke H, Heller A, Bleck C, Ziegler M, Fiedler W, Liehr T, Clement JH, Claussen U. Genes Chromosomes Cancer; 2002 Jun 31; 34(2):193-200. PubMed ID: 11979553 [Abstract] [Full Text] [Related]